Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 30;39(8):e70543.
doi: 10.1096/fj.202402382R.

Targeting MLL1/WDR5-Mediated Epigenetic Regulation Mitigates Peritoneal Fibrosis by Reducing p16INK4a

Daisuke Hara  1 , Kensuke Sasaki  1 , Shigehiro Doi  1 , Takeshi Ike  1 , Kazuya Maeda  1 , Maria Yoshida  1 , Akira Takahashi  1 , Yosuke Osaki  1 , Naoki Ishiuchi  1 , Yujiro Maeoka  1 , Toshiki Doi  1   2 , Takuto Chiba  3 , Ayumu Nakashima  1 , Takao Masaki  1
Affiliations

Targeting MLL1/WDR5-Mediated Epigenetic Regulation Mitigates Peritoneal Fibrosis by Reducing p16INK4a

Daisuke Hara et al. FASEB J. .

Abstract

Peritoneal fibrosis poses a significant challenge to the long-term efficacy of peritoneal dialysis (PD), with emerging evidence highlighting the role of cellular senescence in its pathogenesis. p16INK4a is a cell cycle regulator that has been implicated in cellular senescence. Mixed-lineage leukemia 1 (MLL1) forms a complex with WD-40 repeat protein 5 (WDR5) and exhibits histone H3K4 methyltransferase activity. We have previously shown that inhibition of the MLL1/WDR5 complex reduces p16INK4a expression and attenuates renal senescence after injury in mice. This study aimed to investigate whether inhibiting MLL1/WDR5 attenuates peritoneal senescence, inflammation, and fibrosis in both human samples and in mice with methylglyoxal (MGO)-induced peritoneal fibrosis (MGO-injected mice), while also exploring the associated underlying mechanisms. MLL1/WDR5, histone 3 lysine 4 trimethylation (H3K4me3), and p16INK4a expression were elevated in TGF-β1-stimulated human peritoneal mesothelial cells (HPMCs), non-adherent cells obtained from patients undergoing PD, and the submesothelial compact zones of MGO-injected mice. Notably, p16INK4a expression in these cells was positively correlated with the dialysate/plasma creatinine ratio. Treatment with the MLL1/WDR5 protein-protein interaction inhibitors MM-102 and OICR-9429 reduced H3K4me3 levels and p16INK4a expression, suppressing fibrosis in HPMCs as well as peritoneal fibrosis and inflammation in MGO-injected mice. These inhibitors also improved peritoneal function in MGO-injected mice. Additionally, we demonstrated that MLL1/WDR5-induced H3K4me3 directly regulates p16INK4a gene transcription, and that inhibiting MLL1/WDR5 reduces H3K4me3, thereby suppressing p16INK4a gene transcription. These findings suggest that targeting MLL1/WDR5 activation alleviates peritoneal senescence, inflammation, and fibrosis, highlighting its potential as a promising therapeutic strategy for peritoneal fibrosis.

Keywords: MLL1/WDR5; epigenetics; peritoneal dialysis; peritoneal fibrosis; peritoneal inflammation; senescence.

PubMed Disclaimer

Conflict of interest statement

Disclosure

The authors declare no conflicts of interest.

Conflict of interest: The authors declare no conflicts of interest.

References

    1. Bello AK, Okpechi IG, Osman MA, Cho Y, Cullis B, Htay H, Jha V, Makusidi MA, McCulloch M, Shah N, Wainstein M, and Johnson DW (2022) Epidemiology of peritoneal dialysis outcomes. Nat Rev Nephrol 18, 779–793 - PMC - PubMed
    1. Li PK, Chow KM, Van de Luijtgaarden MW, Johnson DW, Jager KJ, Mehrotra R, Naicker S, Pecoits-Filho R, Yu XQ, and Lameire N (2017) Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 13, 90–103 - PubMed
    1. Strippoli R, Moreno-Vicente R, Battistelli C, Cicchini C, Noce V, Amicone L, Marchetti A, Del Pozo MA, and Tripodi M (2016) Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis. Stem Cells Int 2016, 3543678 - PMC - PubMed
    1. Danford CJ, Lin SC, Smith MP, and Wolf JL (2018) Encapsulating peritoneal sclerosis. World J Gastroenterol 24, 3101–3111 - PMC - PubMed
    1. Zhou Q, Bajo MA, Del Peso G, Yu X, and Selgas R (2016) Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 90, 515–524 - PubMed

MeSH terms

LinkOut - more resources